The Ledger
Memorial Hermann is shutting down its entire commercial health insurance business, the clearest sign yet that health systems are giving up on owning the payer side of the equation. The Houston-based nonprofit, which operates 14 hospitals, notified brokers it will wind down its Commercial Health Plan (HMO), Health Insurance Company (PPO), and Health Solutions administrator products, affecting roughly 50,000 members including about 36,000 in employer-sponsored plans. Groups with renewal dates before December 1, 2026 can elect one final year of coverage, with the business fully terminated by the end of 2027; Memorial Hermann’s Medicare Advantage plan, with about 14,000 members, is not affected. The health plans lost the system $250 million in the most recent fiscal year, with premium revenue of 193.5 million dollars against 163.5 million dollars in member care and insurance expenses, and S&P Global Ratings said the losses have hindered the system’s efforts to boost earnings. Confidence: High. Sources: Healthcare Dive’s report on Memorial Hermann’s exit, Memorial Hermann Health Plan’s program-closing notice.
IKS Health closed its 557 million dollar acquisition of TruBridge, betting that owning both the revenue cycle software and the AI layer on top of it is the way to win the rural hospital market. The deal, first signed in April 2026 and completed July 9, paid TruBridge shareholders 26.25 dollars a share in cash, financed primarily through a new term loan underwritten by Citibank, JPMorgan Chase, and Deutsche Bank. TruBridge brought roughly 347 million dollars in revenue and 69 million dollars in adjusted EBITDA to the deal; the combined company now serves more than 150,000 clinicians and 2,000 healthcare organizations, and IKS says it is chasing a 260 billion dollar total addressable market in rural and community health technology. Confidence: High. Source: IKS Health’s acquisition-completion announcement, BusinessWire.
Centene will pull out of Arkansas’s Medicaid expansion program in 2027, leaving 70,000 beneficiaries to be reassigned as the insurer cites its own funding problems. Centene said its Ambetter, QCA Health Plan, and QualChoice Life and Health plans are “not sustainable for our continued participation in 2027,” pointing to the company’s broader financial pressures as Medicaid faces close to 1 trillion dollars in federal cuts over the next decade. The Arkansas Department of Human Services will automatically transition affected enrollees to the state’s remaining ARHOME insurers, Arkansas Blue Cross Blue Shield, Health Advantage, and Octave, with Centene continuing to participate through the end of this year. Confidence: High. Source: Healthcare Dive’s report on Centene’s Arkansas exit.
ACA marketplace insurers are asking for a median 14 percent premium increase for 2027, the second straight year of double-digit hikes, as the sicker pool left behind by expiring subsidies collides with rising medical costs. The Peterson-KFF Health System Tracker’s analysis of preliminary rate filings from 77 insurers across 16 states and the District of Columbia, published July 8, 2026, found a median 10 percent medical trend plus added pressure from GLP-1 drug utilization, provider labor costs, and the healthier-enrollee exodus that followed the end of enhanced premium tax credits in 2025. Last year’s proposed median increase was 18 percent and finalized at 20 percent; if this year’s filings hold, marketplace premiums will have risen more than a third in two years. Rates are finalized in late summer. Confidence: High on the filing data; Medium on how much of the increase survives state rate review. Source: Peterson-KFF Health System Tracker’s analysis of 2027 ACA marketplace premiums.
Clarivate is selling its Life Sciences and Healthcare data segment to healthcare-focused investment firm Altaris for 600 million dollars, trading a data business for a smaller, more finance-able one. The deal, announced July 6, 2026, pays Clarivate 500 million dollars in cash at closing, plus 25 million dollars deferred and a 75 million dollar seller note; Clarivate says the proceeds will go toward debt reduction and let the company focus on AI-driven intelligence tools for its remaining Academia and Government and Intellectual Property segments. Confidence: High. Source: Clarivate’s divestiture announcement, SEC Form 8-K.
THE DEAL SHEET
| Target | Acquirer/Investor | Vertical | Value | Source |
|---|---|---|---|---|
| TruBridge | IKS Health | Health IT, revenue cycle and EHR | 557 million dollars, 26.25 dollars a share, closed July 9 | IKS Health’s acquisition-completion announcement, BusinessWire |
| Life Sciences & Healthcare segment (Clarivate) | Altaris LLC | Health data and information services | 600 million dollars | Clarivate’s divestiture announcement, SEC Form 8-K |
| Eduro Healthcare (34 skilled nursing facilities, 6 states) | PACS Group | Post-acute, skilled nursing | Undisclosed, expected close Q3 2026 | PACS Group’s acquisition announcement, BusinessWire |
| Exdion Healthcare | Experity | Health IT, AI revenue cycle automation | Undisclosed | Experity’s acquisition announcement |
| DCM BioServices | Surplus Solutions (NMS Capital) | Life sciences, lab automation services | Undisclosed | Surplus Solutions’ acquisition announcement |
Qiagen remains in play, with EQT, Advent, and KKR each still said to be studying a takeover of the 7.85 billion dollar diagnostics maker, but no offer has been made, so it is not listed as a deal yet. No 8-Ks or earnings releases landed in the last 24 to 48 hours from the major payers and health systems we track; UnitedHealth reports Q2 results July 16, Centene reports around July 28, Humana reports July 29, CVS reports August 5.